4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-025504
CHIEF SCIENTIFIC OFFICER sold 847 shares at $30.00 ($25,413)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lyssikatos Joseph P · CHIEF SCIENTIFIC OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-18 | Sale : show line 1 in the form 10b5-1 | −847 | $30.00 | $25,413 | 1,015,188 | I |
| Open-market sales · 847 sh · avg $30.00 · $25,413 | ||||||
Loading xslF345X05/form4-10222024_081010.xml…